IUHC.L vs. GNOM.L
IUHC.L (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) and GNOM.L (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds - IUHC.L tracks the S&P 500 Capped 35/20 Health Care Index while GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF. Both are passively managed. Over the past 3 years, IUHC.L returned 8.05%/yr vs 4.58%/yr for GNOM.L. At a 0.50 correlation, their price movements are largely independent. IUHC.L charges 0.15%/yr vs 0.50%/yr for GNOM.L.
Performance
IUHC.L vs. GNOM.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IUHC.L achieves a 2.89% return, which is significantly lower than GNOM.L's 22.10% return.
IUHC.L
- 1D
- 0.47%
- 1M
- 4.22%
- 6M
- 1.83%
- YTD
- 2.89%
- 1Y
- 21.38%
- 3Y*
- 8.05%
- 5Y*
- 5.73%
- 10Y*
- 9.45%
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
IUHC.L vs. GNOM.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IUHC.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | 2.89% | 14.72% | 2.16% | 1.72% | -2.63% | 6.15% |
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
Correlation
The correlation between IUHC.L and GNOM.L is 0.50, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.50 |
The correlation between IUHC.L and GNOM.L has been stable across timeframes, ranging from 0.47 to 0.50 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IUHC.L vs. GNOM.L — Risk / Return Rank
IUHC.L
GNOM.L
IUHC.L vs. GNOM.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L) and Global X Genomics & Biotechnology UCITS ETF (GNOM.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IUHC.L | GNOM.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.83 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.34 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 2.05 | 3.35 | -1.30 |
| Martin ratioReturn relative to average drawdown | 5.06 | 9.16 | -4.10 |
Loading charts...
Drawdowns
IUHC.L vs. GNOM.L - Drawdown Comparison
The maximum IUHC.L drawdown since its inception was -27.44%, smaller than the maximum GNOM.L drawdown of -69.32%. Use the drawdown chart below to compare losses from any high point for IUHC.L and GNOM.L.
Loading charts...
Drawdown Indicators
| IUHC.L | GNOM.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.44% | -69.32% | +41.88% |
Max Drawdown (1Y)Largest decline over 1 year | -10.40% | -18.91% | +8.51% |
Max Drawdown (3Y)Largest decline over 3 years | -17.62% | -44.77% | +27.15% |
Max Drawdown (5Y)Largest decline over 5 years | -17.62% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -27.44% | — | — |
Current DrawdownCurrent decline from peak | -3.39% | -37.11% | +33.72% |
Average DrawdownAverage peak-to-trough decline | -4.88% | -47.16% | +42.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.21% | 6.92% | -2.71% |
Volatility
IUHC.L vs. GNOM.L - Volatility Comparison
The current volatility for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L) is 5.97%, while Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a volatility of 8.41%. This indicates that IUHC.L experiences smaller price fluctuations and is considered to be less risky than GNOM.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IUHC.L | GNOM.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.97% | 8.41% | -2.44% |
Volatility (6M)Calculated over the trailing 6-month period | 11.61% | 22.18% | -10.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.58% | 29.87% | -14.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.99% | 33.11% | -18.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.77% | 33.11% | -17.34% |
IUHC.L vs. GNOM.L - Expense Ratio Comparison
IUHC.L has a 0.15% expense ratio, which is lower than GNOM.L's 0.50% expense ratio.
Dividends
IUHC.L vs. GNOM.L - Dividend Comparison
Neither IUHC.L nor GNOM.L has paid dividends to shareholders.
Frequently Asked Questions
IUHC.L and GNOM.L have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IUHC.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IUHC.L is cheaper with a 0.15% expense ratio, compared with 0.50% for GNOM.L.
IUHC.L tracks S&P 500 Capped 35/20 Health Care Index, while GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF. They also come from different issuers: iShares and Global X. Their fees differ too: 0.15% for IUHC.L and 0.50% for GNOM.L.
Find the right allocation for IUHC.L and GNOM.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer